S 3304
Showing 1 - 25 of 6,784
Small Cell Lung Carcinoma Trial in Worldwide (coformulation pembrolizumab/quavonlimab, lenvatinib, MK-4830)
Active, not recruiting
- Small Cell Lung Carcinoma
- coformulation pembrolizumab/quavonlimab
- +3 more
-
Gilbert, Arizona
- +46 more
Jan 2, 2023
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
Melanoma, Uveal Tumors Trial in Gothenburg (IHP)
Active, not recruiting
- Melanoma
- Uveal Neoplasms
- IHP
-
Gothenburg, SwedenSahlgrenska University Hospital
Oct 26, 2022
Combined Oral Contraceptives and Body Weight in Pre-Menopausal
Recruiting
- Contraceptive Usage
- +4 more
-
Aurora, Colorado
- +1 more
Jul 20, 2022
Multiple Sclerosis Trial in Worldwide (ACT-128800 Dose 1, Placebo, ACT-128800 Dose 2)
Completed
- Multiple Sclerosis
- ACT-128800 Dose 1
- +3 more
-
Scottsdale, Arizona
- +114 more
Feb 4, 2022
Solid Tumors Trial in United States (S-3304)
Completed
- Solid Tumors
- S-3304
-
Denver, Colorado
- +3 more
Apr 24, 2018
Uterine Diseases Trial in Pozuelo de Alarcón (Hysteroscopy & virtual reality glasses, Hysteroscopy)
Terminated
- Uterine Diseases
- Hysteroscopy & virtual reality glasses
- Hysteroscopy
-
Pozuelo de Alarcón, Madrid, SpainDavid Varillas Delgado
Jan 25, 2023
Schistosoma Related Bladder Diseases.
Not yet recruiting
- Schistosoma Haematobium
- Immunohistochemistry staining,
- microscopic examination of urine
-
Assiut, EgyptAssiut University Hospital
Jul 4, 2023
Non Small Cell Lung Cancer, Lung Cancer, Stage IIIA Non Small Cell Lung Cancer Trial in United States (S-3304,
Completed
- Non Small Cell Lung Cancer
- +3 more
- S-3304
- Chemo-irradiation
-
La Jolla, California
- +4 more
Apr 30, 2018
Elbow Heterotopic Ossifications Associated With Radial Head
Not yet recruiting
- Radial Head Fracture
- Radial head prosthesis
-
Barcelona, Spain
- +1 more
Sep 18, 2022
Obesity, Healthy Volunteers Trial in Dallas (S309309, Itraconazole)
Recruiting
- Obesity
- Healthy Volunteers
-
Dallas, TexasFortrea Clinical Research Unit Inc.
Oct 30, 2023
Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)
Not yet recruiting
- Myeloproliferative Disorders
- +3 more
- (no location specified)
Nov 21, 2023
Hip Fractures, Acute Pain Due to Trauma Trial in Bangkok
Completed
- Hip Fractures
- Acute Pain Due to Trauma
-
Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Jun 3, 2021
2WIN-S Portable Refractor Trial in Bangkok (2WIN-S portable refractor)
Active, not recruiting
- 2WIN-S Portable Refractor
- 2WIN-S portable refractor
-
Bangkok, ThailandRajavithi Hospital
Nov 20, 2023
Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)
Recruiting
- Locally Advanced Gastric Adenocarcinoma
- Chemotherapy Effect
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Birmingham, Alabama
- +43 more
Jan 27, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)
Recruiting
- Serplulimab,Gastric Cancer, Adjuvant Therapy
- Serplulimab
- +2 more
-
Shanghai, ChinaZhang Zizhen
Mar 3, 2023
Multiple Sclerosis Trial in Knoxville (Tolebrutinib, Placebo)
Completed
- Multiple Sclerosis
- Tolebrutinib
- Placebo
-
Knoxville, TennesseeNew Orleans Clinical Research Site Number : 8400001
Oct 24, 2023
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
New York, New York
- +15 more
Jan 27, 2023
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)
Recruiting
- Relapsed or Refractory Multiple Myeloma
-
Edegem, Belgium
- +16 more
Jan 27, 2023